Nuclear SPAC Stock Skyrockets: Terrestrial Energy’s SPAC Deal Ignites Investor Frenzy

Nuclear SPAC Stock Skyrockets: Terrestrial Energy’s SPAC Deal Ignites Investor Frenzy

  • SPAC Merger Vote Imminent: HCM II (NASDAQ: HOND) shareholders will vote Oct. 20, 2025 on a merger with Terrestrial Energy – a Canadian-­US nuclear start­up. [1] [2]. If approved, the combined company will list on NASDAQ as “IMSR” (common) and “IMSRW” (warrants) [3], raising about $280 million at a pro forma equity value near $1.3 billion [4] [5].
  • Stock Surge: Anticipation of the vote sent HOND shares from the high teens to roughly $25 by mid-October [6]. By Oct. 15, the stock traded near $24.98 [7] (close to a 52-week high) on heavy volume, as traders positioned ahead of the merger vote [8] [9]. If the deal closes, HOND holders become shareholders of Terrestrial’s business (ticker IMSR) [10] [11].
  • Advanced Reactor Tech Approved: Terrestrial’s IMSR (Integral Molten Salt Reactor) – a Gen-IV small modular reactor design – just won a major regulatory milestone. The U.S. NRC completed a safety review on Sept. 10, approving Terrestrial’s use of a temperature-based “inherent” control mechanism. It was “the first of its kind… for a molten fuel salt reactor designed for commercial use” [12]. CEO Simon Irish called the approval “a key milestone” that confirms the IMSR’s inherent safety features [13].
  • DOE Endorsement: The U.S. Department of Energy also tapped Terrestrial for its Advanced Fuel Pilot program. In late Sept. 2025 DOE announced selections of Oklo, Terrestrial Energy, TRISO-X, and Valar for advanced nuclear fuel line projects [14]. Terrestrial’s project will develop a fuel salt fabrication process, reinforcing confidence in its supply chain strategy [15] [16].
  • Industry Momentum & Peers: Investors note that Oklo (another SMR developer) just broke ground on its 75 MW Aurora fast reactor at Idaho National Lab [17], and like Terrestrial was chosen in DOE’s fuel program [18]. Meanwhile, tech giants are increasingly backing SMRs – for example, Amazon has disclosed plans to build 12 X-energy SMRs for data centers in Washington state [19]. This broader trend underpins interest in next-­gen nuclear.
  • Analyst Sentiment Mixed: Many analysts see upside if the vote clears. Seeking Alpha columnist Sarfatti initiated coverage with a Buy, noting Terrestrial “stands out” among SMR companies thanks to recent regulatory wins and strong leadership [20]. Major funds are also taking positions: JPMorgan added over $550K of HOND in Q2, and hedge funds boosted their stakes [21]. By contrast, Weiss Ratings still pegs HOND as a “Sell” [22], and SPAC skeptics remind investors that if the deal fails, HOND would collapse back toward its $10 trust value.
  • Technical Indicators: Chart analysts point out that HOND is now well above its 50-day moving average (~$13.6) [23] [24], with most momentum gauges in bullish territory. Financhill reports that short-term moving averages (8-day, 20-day) remain buy signals [25]. In plain terms, the stock’s uptrend has been strong, suggesting room to run if approval occurs. However, rapid run-ups often see pullbacks: HOND is near a 52-week high and overbought on RSI [26], so traders warn profits could be taken once the vote is decided.

Terrestrial Energy is a Generation-IV nuclear developer known for its IMSR technology [27] [28]. The IMSR is a modular molten-salt reactor that uses low-enriched uranium; it is inherently safe thanks to its fuel salt and temperature control design [29] [30]. Terrestrial has been building regulatory momentum: besides the recent NRC ruling, Canada’s regulator completed a positive Vendor Design Review in 2023, finding “no fundamental barriers to licensing” the IMSR for commercial use [31]. The company plans to build first IMSR plants in the early 2030s and markets them not only for electricity but also high-temperature industrial heat (data centers, chemical plants, etc.) [32] [33].

HCM II’s management emphasizes this vision. CEO Simon Irish says the S-4 clearance is a “key transaction milestone” and touts the IMSR as a “transformative” solution to energy demand, noting its safe, low-cost, carbon-free power [34]. HCM II’s Shawn Matthews similarly called the IMSR “a transformative solution for the world’s growing industrial energy needs, delivering safe, reliable and cost-effective power” [35]. Terrestrial is positioned to capitalize on growing demand: it claims a “capex-light” model and highlights DOE programs that could ensure fuel availability [36] [37].

On the market side, HOND’s soaring price has moved its implied enterprise value toward $1.3 billion [38]. If HOND closes at ~$26 (as some reports indicated on Oct. 17), Terrestrial would trade near a $3.5 billion equity valuation at that price. However, analysts caution this is speculative: Terrestrial has no revenue yet and won’t have any commercial sales or profits likely until the 2030s [39]. Even so, many see the deal as a way for retail investors to get early exposure to advanced nuclear technology.

Forecast & Takeaway: In the days ahead, the key events are the Oct. 20 shareholder vote and any new guidance. A smooth approval is widely expected and would likely send HOND/IMSR shares higher, potentially reaching the low-$30s if momentum continues (some technical analysts project targets around $28–$30). If the deal falters (unlikely at this stage), the stock would retrace sharply toward its $10 redemption price. Longer-term, Terrestrial’s success will depend on deploying its IMSR plants and capturing market share in decarbonization. For now, industry veterans like former NRC Commissioner Jeffrey Merrifield say Terrestrial’s regulatory victories “sets a precedent for others in the field” [40], signaling confidence in molten salt reactors. But as analysts note, advanced nuclear remains a high-risk, high-reward sector – one poised for a boom if projects keep meeting milestones, but still uncertain given capital and licensing challenges.

Sources: Latest filings and press releases [41] [42]; industry news [43] [44]; market data from TechStock² and MarketBeat [45] [46]; expert commentary on SMRs [47] [48].

The Nuclear Solution: 5 Must-Know Plays for the AI Energy Surge

References

1. ts2.tech, 2. www.businesswire.com, 3. ts2.tech, 4. ts2.tech, 5. ts2.tech, 6. ts2.tech, 7. ts2.tech, 8. ts2.tech, 9. ts2.tech, 10. ts2.tech, 11. ts2.tech, 12. www.globenewswire.com, 13. www.globenewswire.com, 14. www.energy.gov, 15. ts2.tech, 16. www.energy.gov, 17. www.ans.org, 18. www.energy.gov, 19. www.world-nuclear-news.org, 20. ts2.tech, 21. ts2.tech, 22. ts2.tech, 23. ts2.tech, 24. ts2.tech, 25. ts2.tech, 26. ts2.tech, 27. ts2.tech, 28. www.businesswire.com, 29. ts2.tech, 30. www.globenewswire.com, 31. www.globenewswire.com, 32. www.businesswire.com, 33. www.globenewswire.com, 34. www.businesswire.com, 35. www.businesswire.com, 36. www.energy.gov, 37. www.businesswire.com, 38. ts2.tech, 39. seekingalpha.com, 40. www.globenewswire.com, 41. www.businesswire.com, 42. www.businesswire.com, 43. www.globenewswire.com, 44. www.energy.gov, 45. ts2.tech, 46. ts2.tech, 47. www.globenewswire.com, 48. ts2.tech

Stock Market Today

  • Hang Seng Rebounds Near 25,500 as Nasdaq Dips 3% Amid Mixed Data
    November 9, 2025, 8:08 PM EST. The Hang Seng Index steadied near 25,500 after a weekly gain of about 1.3%, yet traders caution that the correction isn't over. A death cross between the 20-day and 50-day moving averages signals ongoing downside risk, with Wave C still incomplete. If weakness persists, targets around 24,316 loom; a recovery could face resistance near the 27,382 high from mid-April within an ascending channel. On macro data, October trade activity disappointed, while inflation showed mixed signals: CPI rose 0.2% YoY-the fastest since January-yet PPI fell 2.1% in October, improving from September's -2.3%. Sector movers were consumption-oriented names like Tingyi (+11.4%), while New Oriental Education (-10.4%) and Chow Tai Fook (-9.1%) weighed. Watch gold prices and VAT policy changes for jewellery demand.
  • Dow futures climb as bipartisan shutdown deal emerges and ACA subsidies stay in focus
    November 9, 2025, 7:52 PM EST. U.S. stock futures rallied as ABC News reported there are enough Democratic votes in the Senate to advance a short-term funding bill that would end the government shutdown. Dow futures rose about 134 points (0.28%), with S&P 500 and Nasdaq futures up as well. The plan would extend funding through Jan. 31 and cover SNAP and VA costs, but would not extend ACA subsidies-Democrats' central demand. While some House Democrats oppose the bill, the move sets up a Senate vote on subsidy extensions before year-end. Market moves reflected modest gains in rates and currencies, with gold edging higher and oil little changed, as traders weighed political risk against near-term liquidity.
  • Asia-Pacific markets edge higher after AI-driven rout; China inflation beats expectations
    November 9, 2025, 7:40 PM EST. Asia-Pacific markets opened higher after an AI-fueled rout last week, with investors digesting October China inflation data that came in above expectations. The Nikkei 225 rose about 0.5% and the Topix gained 0.4%; 10-year JGB yields climbed to their highest since October. The Kospi jumped around 1.7% led by banks and insurers, while the Kosdaq was flat. The ASX 200 inched up about 0.25%, but Hong Kong Hang Seng futures pointed to a softer session. China CPI rose 0.2% year on year vs. 0% expected, and PPI fell 2.1% y/y, better than the 2.2% decline forecast. In the U.S., the Nasdaq slipped on Friday, though the Dow and S&P 500 were modestly higher on news of a plan to avert a government shutdown.
  • Lifecore Biomedical (LFCR): Is the Stock Price Reflecting True Business Progress?
    November 9, 2025, 7:38 PM EST. Lifecore Biomedical (LFCR) has shown progress in core indicators such as revenue trends, installation of new capacity, and potential product launches, but the stock price action suggests a persistent disconnect between sentiment and fundamentals. Factors behind the gap may include strong hype around the biotech sector, cautious guidance on profitability and cash flow, or delayed product approvals. Investors should watch for near-term catalysts: quarterly results, updated guidance, and any collaborations. If the company demonstrates consistent margin expansion and free cash flow, the valuation multiple could re-rate toward peers.
  • Stock futures rise as government shutdown negotiations progress; investors eye earnings and data
    November 9, 2025, 7:36 PM EST. U.S. stock futures edged higher Sunday night as talks to end the federal government shutdown gain traction. S&P 500 futures rose about 0.5%, Nasdaq-100 futures up 0.7%, and Dow futures about 0.3%. Investors monitor Washington for a funding deal to reopen the government and resume key data releases delayed by the 39-day shutdown. Senate leaders signaled a bipartisan framework may be taking shape, potentially reopening through January and addressing some federal layoffs, though health-care subsidies remain unsettled. The shutdown has dampened sentiment, with the University of Michigan's consumer sentiment index near three-year lows and upcoming CPI/PPI data postponed. Attention shifts to earnings this week, including CoreWeave, Oklo, Rocket Lab, as well as Disney and Paramount Skydance results.
APLD Stock Skyrockets on AI Data-Center Boom – What’s Driving the Rally?
Previous Story

APLD Stock Skyrockets on AI Data-Center Boom – What’s Driving the Rally?

GSI’s AI Breakthrough Slashes Energy by 98% – GPU-Killer Chip Sparks 200% Stock Rally
Next Story

GSI’s AI Breakthrough Slashes Energy by 98% – GPU-Killer Chip Sparks 200% Stock Rally

Go toTop